Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Heghine Khachatryan: Less Frequent INR Monitoring – Does It Necessarily Mean Poorer Anticoagulation Control?
Heghine Khachatryan/LinkedIn
Aug 9, 2026, 07:32

Heghine Khachatryan: Less Frequent INR Monitoring – Does It Necessarily Mean Poorer Anticoagulation Control?

Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared Thrombosis Update’s post on LinkedIn:

“Less frequent INR monitoring — does it necessarily mean poorer anticoagulation control?

An important real-world observation from a Dutch dynamic cohort study published in Thrombosis Update challenges an assumption deeply embedded in VKA management: that reducing INR testing frequency will inevitably compromise anticoagulation stability.

During the COVID-19 pandemic, INR monitoring became less frequent compared with the pre-pandemic period. Yet, importantly, this temporary reduction did not appear to impair VKA stability.

The message is nuanced.

Regular INR monitoring remains a cornerstone of safe and effective vitamin K antagonist therapy. However, in appropriately selected, clinically stable patients, the optimal monitoring strategy may be more individualized than a rigid testing schedule suggests.

For me, the broader lesson extends beyond the pandemic:

Good anticoagulation management is not simply about how often we measure INR—it is about identifying when monitoring adds meaningful clinical value and adapting follow-up to the stability and risk profile of the individual patient.

This raises an interesting question for contemporary anticoagulation practice:
Can we move from fixed INR-monitoring intervals toward more personalized, risk-adapted monitoring strategies in stable VKA-treated patients?”

Thrombosis Update shared a post on LinkedIn about a recent article by Tessa Elling et al., adding:

“This dutch dynamic cohort study in Thrombosis Update reported decreased INR testing frequency during the COVID19 compared with the pre-pandemic period.

Here is the link of the the associated editorial commentary.”

Title: Impact of reduced INR monitoring frequency on anticoagulation control during the COVID-19 pandemic: A dutch dynamic cohort study

Authors: Tessa Elling, Nic J.G.M. Veeger, Derk Hardeman, Adrian Kruit, Jos G.J. Pouwels, Jenneke Stegeman, Vladimir Tichelaar, Karina Meijer

Heghine Khachatryan

Stay updated on all scientific advances with Hemostasis Today.

Adrian Kruit Derk Hardeman Health Heghine Khachatryan Hematology Hemostasis Hemostasis News Hemostasis Today Jenneke Stegeman Jos G.J. Pouwels Karina Meijer Medicine Nic J.G.M. Veeger Tessa Elling Thrombosis Update Vladimir Tichelaar
NewsFeed